Is Goodrx Holdings Inc (GDRX) overvalued? · P/E 49, rev $394.4M
Goodrx Holdings Inc (GDRX) is a health information services company listed on US.
This page asks whether Goodrx Holdings Inc (GDRX) looks expensive on cached numbers — not a short thesis.
Latest reported GDRX revenue for 2026-06-30 was $394.4M. Net income was $9.7M. GDRX currently screens at market cap $988.9M and trailing P/E 48.7.
GDRX currently screens at market cap $988.9M and trailing P/E 48.7. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next GDRX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the GDRX stock page for the full model, not this heading.
Not investment advice.